Esperion Therapeutics, Inc. - Common Stock (ESPR)
$1.73
0.00 (0.00%)
ESPR Stock Quote Delayed 30 Minutes
ESPR Stock Earnings: Esperion Therapeutics Beats EPS, Beats Revenue for Q2 2024
ESPR stock results show that Esperion Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
48.92M
PE Ratio
-2.70
EPS
-0.64
Volume (Avg. Vol.)
12,557
Day's Range
-
52-Week Range
$1.58 - $3.94
Dividend & Yield
N/A (N/A)
ESPR Stock Predictions, Articles, and Esperion Therapeutics, Inc. - Common Stock News
Why Is Esperion Therapeutics (ESPR) Stock Up 13% Today?
Esperion Therapeutics stock is up on Tuesday with heavy trading of ESPR shares after the company beat EPS and revenue estimates in Q1.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning.
Why Is Esperion Therapeutics (ESPR) Stock Down 24% Today?
Esperion Therapeutics stock is down on Friday after the company announced a public offering for 56.7 million shares of ESPR.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
We're starting the final day of trading this week with a look at the biggest pre-market stock movers for Friday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day off right with a look at the biggest pre-market stock movers to watch for Thursday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start breaking down the biggest pre-market movers for Thursday as we get ready for another busy day of trading!
Why Is Esperion Therapeutics (ESPR) Stock Down 60% Today?
Esperion Therapeutics (ESPR) stock is taking a beating on Thursday as the company comes into conflict with Daiichi Sankyo Europe.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time for another dive into the biggest pre-market stock movers as we go over all the latest news for Thursday morning!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, investor! We're at the end of the week and it starts off with the biggest pre-market stock movers for Friday!
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting the last day of this short holiday week with a dive into the biggest pre-market stock movers for Wednesday!
12 Most Highly Shorted Stocks Heading Into Q3 2021
Investors are seeking out the most highly shorted stocks. With GME and AMC seeing monolithic gains, can the same thing be done elsewhere?
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Here at InvestorPlace, we're starting the day off like we always do with a look at the biggest pre-market stock movers for Wednesday.
Esperion Therapeutics Inc Shares Plunge on Cholesterol Drug Safety Concerns
Esperion Therapeutics (ESPR) stock was falling hard Wednesday following the release of results from its Phase 3 trial for bempedoic acid.
40 Biotechnology Stocks to Sell Now
This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
40 Biotechnology Stocks to Sell Now
The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Biggest Movers in Manufacturing Stocks Now – OCUL LNN AEZS ESPR
The following stocks were moving the Manufacturing sector today.
